A Study in Participants With Non-cirrhotic NASH With Fibrosis
NCT05638737
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
112
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
Interventions
DRUG:
AZD4831
OTHER:
Placebo
Sponsor
AstraZeneca